COMMUNIQUÉS West-GlobeNewswire

-
Emerald Health Therapeutics annonce les résultats financiers du quatrième trimestre et de l’exercice 2018; faits saillants entourant la croissance des ventes au T1 2019
04/05/2019 -
RavenQuest Awarded its First Cannabis Sales License from Health Canada
03/05/2019 -
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/05/2019 -
Align Technology to Speak at Upcoming Financial Conferences
03/05/2019 -
Les vendeurs de Verdélite recevront des actions d’Emerald au lieu d’un paiement comptant
03/05/2019 -
Guardant Health to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
03/05/2019 -
Pacific Biosciences of California, Inc. Announces First Quarter 2019 Financial Results
03/05/2019 -
Align Provides Update on Patent Infringement Case Against 3Shape
03/05/2019 -
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2019
03/05/2019 -
EssilorLuxottica : Nombre total de droits de vote et d’actions composant le capital social au 30 avril 2019
03/05/2019 -
Synergy CHC Corp. Announces First Quarter 2019 Results
03/05/2019 -
Motif Bio meeting with U.S. FDA held as planned
03/05/2019 -
SRS Health to Showcase Latest Enhancements and Integrations at the American Association of Orthopaedic Executives in Nashville, TN
03/05/2019 -
Mereo BioPharma Group plc (“Mereo” or the “Company” or the “Group”) Intention to Purchase Shares by Trustee of Employee Benefit Trust
03/05/2019 -
ORION CORPORATION: ACQUISITION OF OWN SHARES 03.05.2019
03/05/2019 -
Athenex Announces Promising Early and Complete Response Data from a Clinical Study of Oraxol in Cutaneous Angiosarcoma
03/05/2019 -
Precipio Successfully Completes Nasdaq Hearing Process
03/05/2019 -
CohBar to Resume its Phase 1a/1b Clinical Trial
03/05/2019 -
Today's Disruptors In North American Cannabis Retail
03/05/2019
Pages